Deprecated: Implicit conversion from float 225.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 225.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 225.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32404652
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 J+Addict+Med
2020 ; 14
(4
): e8-e9
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Innovation During COVID-19: Improving Addiction Treatment Access
#MMPMID32404652
Samuels EA
; Clark SA
; Wunsch C
; Jordison Keeler LA
; Reddy N
; Vanjani R
; Wightman RS
J Addict Med
2020[Jul]; 14
(4
): e8-e9
PMID32404652
show ga
: During the COVID-19 pandemic, many addiction treatment and harm reduction
organizations have had to reduce their hours and services for people with
substance use disorders, placing these individuals at increased risk of death. In
order to address restricted treatment access during COVID-19, guidance from the
Substance Abuse Mental Health Services Administration, the US Drug Enforcement
Administration, and the US Department of Health and Human Services has allowed
for use of audio-only telehealth encounters for buprenorphine induction without
requiring an in-person evaluation or video interface. This has enabled
innovations in order to try to meet the needs of the most vulnerable among us
during the current pandemic. In this new regulatory environment, we established
the Rhode Island Buprenorphine Hotline, a phone hotline which functions as a
"tele-bridge" clinic where people with moderate to severe opioid use disorder can
be linked with a DATA 2000 waivered provider who can provide an initial
assessment and, if appropriate, prescribe buprenorphine for unobserved induction
and linkage to outpatient treatment. In this correspondence we briefly share our
experience developing this common sense approach to addressing the complex
problem of access to treatment only now permissible due to regulatory changes
during COVID-19.
|*Coronavirus Infections/epidemiology/prevention & control
[MESH]
free
free
free
